Home > PS Ratio > AURO LABORATORIES

AURO LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of AURO LABORATORIES is 2.39.

Share Price ₹212.3Apr 26,2024
Market Cap ₹131.6 Cr
Sales-TTM₹55.1 CrTTM-Standalone Results
Price/Sales2.39xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results
AURO LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of AURO LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of AURO LABORATORIES is calculated as :

Current Market Cap [ ₹131.6 Cr] as on Apr 26,2024

(/) Sales [ ₹55.1 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 2.39x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for AURO LABORATORIES , the investors are currently willing to pay '2.39 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of AURO LABORATORIES !

The chart below summarizes the trend in P/S Ratio of AURO LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of AURO LABORATORIES


PS Ratio Performance Analysis for AURO LABORATORIES

- AURO LABORATORIES 's latest p/e ratio is 2.39x.

- AURO LABORATORIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.81x.

- AURO LABORATORIES 's operated at median p/e ratio of 0.79x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AURO LABORATORIES 's p/e ratio peaked in Mar2022 at 1.23x.

- AURO LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 0.45x.


How does AURO LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
AURO LABORATORIES 55.12.39131.6
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.61360,920.0
CIPLA LTD25,350.24.49113,794.0
DR REDDYS LABORATORIES LTD27,212.53.83104,316.0
ZYDUS LIFESCIENCES LTD19,024.25.0195,380.9
DIVIS LABORATORIES LTD7,492.814.26106,860.0
MANKIND PHARMA LTD9,946.39.5494,869.4
TORRENT PHARMACEUTICALS LTD10,474.08.6991,057.0
LUPIN LTD19,480.13.7873,642.4
AUROBINDO PHARMA LTD27,894.72.3866,278.5
ABBOTT INDIA LTD5,753.49.5554,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs AURO LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.38x
Max industry PS 14.26x
Median industry PS 5.01x
Average industry PS 6.50x



You may also like the below Video Courses